Virax Biolabs Group Limited Ordinary Shares (VRAX) is a publicly traded Healthcare sector company. As of May 21, 2026, VRAX trades at $0.30 with a market cap of $1.74M and a P/E ratio of 0.00. VRAX moved +2.30% today. Year to date, VRAX is -16.86%; over the trailing twelve months it is -70.87%. Its 52-week range spans $0.10 to $3.62. Rallies surfaces VRAX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Virax Biolabs Group Limited Ordinary Shares (VRAX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. VRAX moved +2.30% today.
| Metric | Value |
|---|---|
| Price | $0.30 |
| Market Cap | $1.74M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.62 |
| 52-Week Low | $0.10 |
| Volume | 21.96M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
VRAX analyst coverage data. Average price target: $0.00.